Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy
Dan Liu(Machine Intelligence Research Institute), Zhaohui Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Kongshuo Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuang Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuanwei Pan(National University of Singapore), Kaiqing Yun(Chinese Academy of Medical Sciences & Peking Union Medical College), Lang Rao(Shenzhen Metro (China)), Xiaoyuan Chen(Agency for Science, Technology and Research), Qian‐Fang Meng(Shenzhen Bay Laboratory), Jian Wei(Capital Medical University), Mengli Zhou(Zhejiang Sci-Tech University), Xingang Li(Capital Medical University)
Cited by 108
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.3k
Majorbio Cloud: A one‐stop, comprehensive bioinformatic platform for multiomics analyses
|iMeta|2022|857
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|398
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
|Nature Communications|2020|373
Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
|Advanced Materials|2020|278